Abstract. The subcellular distribution of microtubules containing acetylated a-tubulin in mammalian cells in culture was analyzed with 6-11B-l, a monoclonal antibody specific for acetylated a-tubulin. Cultures of 3T3, HeLa, and PtK2 cells were grown on coverslips and observed by immunofluorescence microscopy after double-staining by 6-11B-1 and B-5-1-2, a monoclonal antibody specific for all ¢t-tubulins. The antibody 6-11B-1 binds to primary cilia, centrioles, mitotic spindles, midbodies, and to subsets of cytoplasmic microtubules in 3T3 and HeLa cells, but not in PtK2 cells. These observations confirm that the acetylation of a-tubulin is a modification occurring in different microtubule structures and in a variety of eukaryotic cells. Some features of the acetylation of cytoplasmic microtubules of mammalian cells are also described here. First, acetylated a-tubulin is present in microtubules that, under depolymerizing conditions, are more stable than the majority of cytoplasmic microtubules. In addition to the specific microtubule frameworks already mentioned, cytoplasmic microtubules resistant to nocodazole or colchicine, but not cold-resistant microtubules, contain more acetylated a-tubulin than the rest of cellular microtubules. Second, the ¢t-tubulin in all cytoplasmic microtubules of 3T3 and HeLa cells becomes acetylated in the presence of taxol, a drug that stabilizes microtubules. Third, acetylation and deacetylation of cytoplasmic microtubules are reversible in cells released from exposure to 0°C or antimitotic drugs. Fourth, the epitope recognized by the antibody 6-11B-1 is not absolutely necessary for cell growth and division. This epitope is absent in PtK2 cells. The acetylation of et-tubulin could regulate the presence of microtubules in specific intracellular spaces by selective stabilization.
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T
IlE majority of ¢t-tubulin assembled in the axonemes of Chlamydomonas flagella is acetylated on the e-amino group of a lysine residue (6) . Acetylation of this lysine is catalyzed in the flagellar matrix (5, 3) , and deacetylation occurs in the cell body when flagella are resorbed (7) . On the basis of these observations, UHernault and Rosenbaum proposed that acetylation and deacetylation of ¢t-tubulin have a function in regulating the assembly of axonemal microtubules. Subsequent studies, including this one, showed that acetylated ct-tubulin is present in various microtubule structures and may have a role in stabilizing the structure of all microtubules.
The analysis of interphase Chlamydomonas cells by a monoclonal antibody specific for acetylated et-tubulin provided evidence for the presence of the antigen in basal bodies and in subsets of cytoplasmic microtubules (8) . The same antigen was detected in cilia and flagella of a variety of cells (12) . Cytoplasmic microtubules containing acetylated ¢t-tubulin in Chlamydomonas were found to be more resistant than other cellular microtubules to the effects of antimitotic drugs (8) . As acetylated a-tubulin was found in three microtubule structures of Chlamydomonas and in axonemes of various cells, we wanted to investigate whether the modified subunit is also present in cytoplasmic microtubules of other cell types and in different microtubule frameworks. A more general model of the function of the acetylation could result from this study. We report here the analysis of three cell lines, 313, HeLa, and PtK2, by two monoclonal antibodies, one specific for acetylated ¢t-tubulin, the other specific for all ¢t-tubulins.
Materials and Methods

Cell Culture
3T3, flbroblast-like cells from mouse embryo, were provided by Dr. David Foster (Rockefeller University, NY); HeLa, epithelial-like cells from epitheloid carcinoma of human cervix, were provided by Dr. Nathaniel Heintz (Rockefeller University); and PtK2, epithelial-like cells from kidney of Potorous tridactylis, were obtained from the American Type Culture Collection (cat. No. CCL 56; Rockville, MD). Cells were grown on glass coverslips in MEM supplemented with 10% FCS, penicillin, and streptomycin (100 U/ml) at 37°C in 5% CO2. Subcultures of ceils were performed at a density of 1.6 x 104 or 0.3 x 104 cells/35-mm dish 2 or 3 d before staining. Ceils used for experiments of antibody binding to soluble proteins were collected from confluent cultures. In some experiments culture medium was substituted with fresh medium containing 10 IxM taxol (Natural Products Branch of National Cancer Institute, Bethesda, MD) or 10 ~tg/ml cycloheximide (Sigma Chemical Co., St. Louis, MO), or 0.1 or 1 lag/ml nocodazole (Aldrich Chemical Co., Gillingham, England), or 10-6M colchicine (AI-drich Chemical Co.). Recovery from exposure to nocodazole, colchicine, or taxol was performed by washing the coverslips once in medium and placing them in new 35-mm culture dishes containing 4 ml of fresh medium at 37°C. Recovery from exposure to 0°C was performed without substitution of medium. The 35-mm culture dishes, containing 4 ml of medium, and the coverslips were warmed to 37°C in 15 min.
Monoclonal Antibodies
The monoclonal antibodies 6-UB-1, B-5-1-2, and C-241-2 were used in culture medium or as pure IgGs. IgGs were purified from serum-free culture medium (HB 102 medium, New England Nuclear, Boston, MA) by Protein A-Sepharose affinity chromatography. The antibody 6-lIB-1 is specific for acetylated ¢t-tubulin (12) and antibody C-241-2 is specific for the 13-subunit of dynein from the outer arms of Strongylocentrotus purpuratus sperm axonemes (11) . Antibody B-5-1-2 recognizes all tt-tubulin isoforms in Chlamydomonas, sea urchin, and human tubulin. The hybridoma B-5-1-2 produces an IgG and was selected among hybridomas derived from the fusion of the myeloma P3UI with mouse spleen cells, as previously described. The mouse was immunized with Sarkosyl-resistant filaments (9) from S. purpuratus sperm axonemes. Four hybridomas secreting monoclohal antibodies against ¢t-tubnlin were isolated. The antibody B-5-1-2 was selected because it has high affinity and reacts with all a-tubutin isoforms (Chang, X.-J., and G. Piperno, unpublished results).
Immunofluorescence
Cells on coverslips were exposed to 1% Triton X-100, 2 mM EGTA, 5 mM Pipes (Sigma Chemical Co.), pH 6.7, for 1 min at room temperature, then placed in methanol cooled on solid CO2 for 5 rain, warmed for 5 rain, and rehydrated for 5 rain in 0.13 M NaCi, 0.01 M sodium phosphate, pH 6.8 (PBS). Chemical acetylation in situ was performed by exposing methanol fixed cells to 0.1% acetic anhydride, 1 M sodium phosphate, pH 8, for 1 min before rehydrating and washing them in PBS. The incubation of cells with antibody 6-1113-1 was performed overnight at 8"C. Biotin-labeled sheep antimouse antiserum (Amersham Corp., Arlington Heights, IL; diluted 1:25), antibody B-5-1-2, and fluorescein-labeled goat antimouse (Cappell Laboratory, Malvern, PA; diluted 1"50), Texas Red Streptavidin (Amersham Corp.; diluted 1:25), were subsequently applied to the cells for 1 to 2 h at room temperature. All dilutions were in 0.1% BSA in PBS. Incubations were performed in a humid chamber. Three washings in PBS for 7 min were performed with shaking after each incubation. Coverslips were then inverted on a slide over a drop of 90% vol/vol glycerol, 10% voi/vol PBS, 1 mg/ml p-phenylene diamine (pH 7.15), and maintained in place with nail polish.
Controls of the permeabilization and fixation procedures were performed on 3T3 cells. Prolonging the time of exposure to the Triton X-100 solution or inverting the order of the operations concerning the exposure to Triton and to methanol or fixing the cells with 1% glutaraldehyde in 100 mM Tris/HC1 (pH 7.5), 15 mM EGTA, and 2.5 mM MgCI2 did not alter the staining patterns of antibodies 6-11B-I or B-5-1-2. However each of these procedures produced labeling of microtubules that was less contrasted over the background than that shown in the Results section.
Controls of specificity of the antibody binding included the application of antibody C-241-2 as negative control, single-labeling procedures with antibody 6-11B-I or B-5-1-2, and application of pure 6-11B-1 or C-241-2 IgGs up to concentrations of 50 Ixg/ml. In each case it was confirmed that the staining patterns obtained with 6-11B-1 or B-5-1-2 were specific and were not altered by the double-staining procedure or by the presence of culture medium.
Photomicrographs were obtained using a Zeiss Photomicroscope II equipped with an epi-fluorescence condenser III RS and a 63 X Planapo objective. The exposure times varied from 30 to 90 s. The film, Kodak Tri X Pan, was developed in D76 developer.
Electrophoresis, Immunoblotting, and Dot lmmunobinding
Protein samples from 3T3 cells grown overnight in the presence or absence of 10 I.tM taxol were prepared by scraping the cells from the dishes in PBS containing 1 mM EDTA. After sedimentation the cells were suspended in 0.1 ml per plate of a solution containing 0.1 mM phenyl methyl-sulfonyl fluoride (PMSF) and 0.1 mg/ml soybean trypsin inhibitor. The suspension was sonicated 15 s at 50 W, then SDS was added to the concentration of 1%. The samples were boiled and immediately used for electrophoresis or for dot binding assays.
To prepare fractions containing unpolymerized or polymerized tubulin from taxol-treated 3T3 cells, cells were grown, collected, and washed as described above. The cell pellet was then resuspended in 10 vol of 0.5 % NP-40, 0.14 M NaCI, 2 mM MgSO4, 2 mM EGTA, 10 mM Tris/C1 pH 7.6, 10 gM taxol, 0.1 mM PMSE 0.1 mg/ml soybean trypsin inhibitor, and left on ice for 10 min. The suspension was then centrifuged for 30 rain at 37°C and 20,600 rpm in a rotor (model SW65; Beckman Instruments, Inc., Fullerton, CA). The pellet was resuspended by sonication as described. Both supernatants and pellets were prepared for analysis as described. Control experiments, performed on untreated 3T3 cells, indicated that under these conditions the addition of taxol during and after the lysis did not induce the acetylation of ct-tubulin or the polymerization of microtubules.
Protein samples from PtK2 cells were prepared from cultures treated with 10 Ixg/ml nocodazole for 30 rain. Cells were detached by adding 3 ml per 100 mm plate of a medium containing 0.25% trypsin and l0 gg/ml nocodazole for 8 min, at 37°C. The trypsin was removed and the cells were collected in medium containing 10 gg/ml nocodazole. After sedimentation and a wash in PBS containing 10 p.g/ml nocodazole and 0.1 mg/ml soybean trypsin inhibitor, the cell pellet was suspended in 5 vol of 0.14 M NaC1, 1.5 mM MgCI2, 10 mM Tris/C1, pH 8.6. Then NP-40 was added to a final concentration of 0.5 % and the suspension was left on ice for 10 min before being spun down at 12,000 g for 5 rain. The pellet was discarded and the supernatant was diluted 1:1 with 2 M sodium phosphate, pH 8.0. One-half of the sample was acetylated in vitro by adding 1% vol/vol acetic anhydride for 10 min at room temperature. SDS was added to a final concentration of 0.1% to acetylated and unacetylaleM samples, which were then dialyzed against 0.1% SDS, 15 mM 13-mercapto-ethanol, 1 mM EDTA, 40 mM Tris/Borate, pH 8.65, and analyzed as described above.
Electrophoresis of polypeptides, transfer to nitrocellulose, and detection of antigens by monoclonal antibodies was performed as described previously (11) . Samples were processed for quantitative dot-immunobinding assay as described by Jahn et al. (4) and modified by Piperno and Fuller (12) .
Results
Subsets of Cytoplasmic Microtubules and Specific Microtubule Frameworks Contain Acetylated a-Tubulin
We observed by fluorescence microscopy 3T3, HeLa, and PtK2 cells that were grown on glass coverslips and processed for double-label immunofluorescence, as described in Materials and Methods. Double-label staining of microtubules was performed with 6-11B-l, a monoclonal antibody specific for acetylated a-tubulin, and with B-5-1-2, a monoclonal antibody that recognizes all a-tubulin isoforms in a variety of organisms.
Subcellular locations of all microtubules in interphase 3T3, HeLa, and PtK2 cells are shown in Fig. 1 , a', b', and c'. Although the length, shape, and density of microtubules give each cell line a characteristic appearance, classical patterns of microtubules radiating from the perinuclear region toward the edge of the cells are visible in 3T3 cells ( Fig. 1  a' ), HeLa cells ( Fig. 1 b' ), and PtK2 cells ( Fig. 1 c' ). Microtubules containing acetylated ct-tubulin are present in 3T3 cells ( Fig. 1 a) , and HeLa cells ( Fig. 1 b) , but are not seen in PtK2 cells (Fig. 1 c) . In 3T3 cells, acetylated ct-tubulin is found in segments of a few microtubules (see cross in Fig.  1 a) and in short structures radiating from the centrosphere (see arrows in Fig. 1 a) . These structures appear to be primary cilia. In some areas of the coverslips where 3T3 cells were confluent, a higher amount of microtubules containing acetylated ct-tubulin was observed. In HeLa cells, acetylated ¢t-tubulin is assembled in microtubules that seem to be concentrated about the cell center: some are curved and not oriented toward the centrosphere (Fig. 1 b) .
Cells undergoing mitosis or cytokinesis were also examined. Again 3T3 al~d HeLa, but not PtK2 cells, were labeled by the antibody 6-11B-l, which is specific for acetylated a-tubulin. Mitotic spindles of 3T3 cells (Fig. 2 , a and a') and HeLa cells (Fig. 2, b and b') were stained by both antibodies 6-lIB-1 and B-5-1-2. Therefore, polar regions, kinetochores, and continuous fibers of the spindles contain acetylated a-tubulin. The same antigen is present in midbodies of 3T3 cells (Fig. 2 c) and HeLa cells (Fig. 2 d) .
In summary, subsets of cytoplasmic microtubules and well defined microtubule structures such as primary cilia, mitotic spindles, and midbodies contain acetylated a-tubulin in 3T3 and HeLa cells. In PtK2 cells the epitope recognized by the monoclonal antibody, 6-11B-I, is either absent or masked. The experiments performed to test these hypotheses are described in the last section of Results. 
Taxol-stabilized Microtubules Become Acetylated on a-Tubulin
Microtubules found in the structure of primary cilia and midbodies differ in two properties from the majority of cytoplasmic microtubules. First, they form regular frameworks that contain various appendages. Second, they are more stable than other cytoplasmic microtubules under conditions that promote microtubule disassembly (2) . Cellular structures that cross-link the microtubules along their length or cap their ends may cause this stabilization (2) . Formation of ordered structures and stability of microtubules have also been correlated with the presence of acetylated ct-tubulin in the microtubules of Chlamydomonas (8) . We wanted to investigate whether this correlation is verified for cytoplasmic microtubules that are stabilized by taxol, an antimitotic drug that induces microtubule assembly and formation of micro- tubule bundles (10, 13) . Cytoplasmic microtubules, which normally disassemble and assemble at high rates, in the presence of taxol bind the drug and are stabilized (13) .
Cells that were cultured overnight in the presence of 10 ~tM taxol were processed for double-label immunofluorescence microscopy, as described before. 313 cells are shown in Fig. 3, a and Fig. 3, a', b' , and c') reveals that bundles of microtubules were formed in each cell line. The staining with the antibody 6-11B-l, against acetylated a-tubulin, is nearly identical to that obtained by B-5-1-2 in 313 and HeLa cells, but is completely absent in PtK2 cells (Fig. 3, a-c) . These results show that an increase of polymerized, acetylated a-tubulin is induced in the presence of taxol in 313 and HeLa cells. Taxol bound to microtubules of PtK2 cells because it formed bundles of microtubules. However, even under this condition, the antibody 6-11B-1 does not recognize any epitope in PtK2 cells.
The effect of exposure to taxol was also analyzed by bind- The same conclusions were reached by dot assay on increasing amounts of proteins from treated and untreated cells. Table I shows that the binding of the antibody 6-11B-1 to proteins of 313 cells increased severalfold after treatment of the cells with taxol. Since the immunoblot shown in Fig.  4 b confirmed the monospecificity of the antibody 6-11B-l, this increased binding indicates that the concentration of acetylated tz-tubulin rises in these cells..Taxol treatment also raised the total concentration of ~t-tubulin in the cells, as evidenced by the increased binding of the antibody B-5-1-2. However, the relative increase of total ¢t-tubulin is much lower than that of acetylated ~t-tubulin. These results indicate that upon exposure to taxol, acetylation of tt-tubulin occurs. An increase in the acetylation of a-tubulin in taxoltreated 3T3 cells could be detected after 30 min of exposure. Maximal acetylation was reached in 12 h (not shown). 
Drug-resistant but Not Cold-resistant Microtubules Contain More Acetylated a-Tubulin than the Majority of Cytoplasmic Microtubules
A second approach to the investigation of whether stable cytoplasmic microtubules contain acetylated a-tubulin employed antimitotic drugs that promote microtubule disassembly. Previous experiments showed that in Chlamydomonas cell bodies a subset of cytoplasmic microtubules are acetylated and are much more resistant to drug-induced depolymerization than nonacetylated microtubules (8) . We describe here observations performed by immunofluorescence microscopy of 3T3 and HeLa cells after they are exposed to 0.1 p.g/ml nocodazole for 30 min or 10 -6 M colchicine for 1 h. In all instances the majority of cytoplasmic microtubules were depolymerized and most of the residual microtubules were stained by 6-11B-l, the antibody against acetylated ct-tubulin. Double-label immunofluorescence was performed as previously described. Staining by the antibody 6-11B-1 is shown in Fig. 5, a-d . 3T3 cells exposed to nocodazole are shown in Fig. 5, a and a' . The same cells exposed to colchicine are shown in Fig. 5, c and c' . In both cases the few microtubules that are distinguishable as single filaments appear to contain acetylated ¢t-tubulin at least in part of their length. Similar patterns of staining are seen in HeLa cells treated with nocodazole (Fig. 5, b and b' ) or colchicine (Fig. 5, d and d') .
The resistance of these residual microtubules is not absolute. Fig. 6 , a and a' shows that 3T3 cells exposed to 1 Ilg/ml nocodazole for 30 min contain few cytoplasmic microtubules and primary cilia. Acetylated ct-tubulin is present in these residual structures.
We observed that in Chlamydomonas all cytoplasmic microtubules are depolymerized upon exposure to 0°C, independently of their content of acetylated ~t-tubulin (8) . Although exposure of cells to 0°C affects microtubules as well as most cellular structures, and therefore may not be considered a specific treatment for testing microtubule stability, we wanted to investigate whether cold resistant microtubules, which exist in 3T3 and HeLa cells, are enriched in acetylated ¢t-tubulin like the drug-resistant microtubules. (Fig. 6 b' ) and in HeLa cells at mitosis, where kinetochore fibers are conserved in the spindle (inset in Fig. 6 c') . In contrast, no microtubule survived the exposure m O°C in HeLa cells at interphase (Fig. 6 c') . Fig. 6 b shows that 3T3 cells contain acetylated ct-tubulin in primary cilia, centrioles, and in few of the cold resistant microtubules. Fig. 6 c shows that HeLa cells contain acetylated a-tubulin in kinetochore fibers (see inset) and in small paired structures that presumably are centrioles. Microtubules resistant to cold may or may not contain acetylated a-tubulin.
The Acetylation of a-Tubulin Is Reversible
The question of whether acetylated ¢t-tubulin i~ ~'msent in the cells in a monomeric form of modified tubulin was inves- tigated by qualitative experiments of binding of either of the two antibodies, 6-lIB-1 or B-5-1-2. The binding was tested against fractions of protein containing soluble tubulin or microtubules that were prepared from taxol-treated or untreated 3T3 cells, as described in Materials and Methods. Fig. 7 a shows electrophoretograms of ~40 Ixg of protein from supernatant and pellet fraction. The electrophoretograms are composed of a large number of unresolved bands but they are different. Fig. 7, b and c shows immunoblots of the same samples incubated with the antibody 6-11B-1 or B-5-1-2. The antibody B-5-1-2 identifies one band of a-tubulin in both lanes, but the intensity of the bands indicates that the concentration of soluble a-tubulin is lower than that of polymerized ¢t-tubulin (Fig. 7 c) . The antibody 6-11B-1 only detects a large amount of acetylated a-tubulin in the fraction containing microtubules (Fig. 7 b) . Supernatant fractions from untreated 3T3 cells contained more tubulin than pellet fractions, but traces of acetylated ct-tubulin were detected only in the latter (not shown). These results indicate that acetylated a-tubulin in taxol-treated or untreated cells is present mainly or exclusively in polymeric form.
3T3 cells treated with 1 Ig/ml of nocodazole for 30 min and HeLa cells exposed to 0°C for 1 h do not have a cytoskeleton of microtubules (see Fig. 6, a' and c') . They maintain microtubules only in centrioles and primary cilia and rapidly form a cytoplasmic system of microtubules upon restoration of normal conditions of culture (2) . Since the acetylation of ct-tubulin may occur primarily or exclusively on assembled tubulin, we had the opportunity of observing where and when the acetylation is detected during the recovery from exposure to nocodazole or cold.
Assembly of cytoplasmic microtubules starts in the region of the centrosphere, which is marked by the presence of cen- trioles and primary cilia. These structures already contain acetylated ct-tubulin and are labeled by both antibodies 6-11BA and B-5-1-2. Fig. 8 , a and a' shows 3T3 cells recovering under normal conditions of culture 90 s after treatment with 1 gg/ml nocodazole for 30 min. Aster-like structures of microtubules are stained by the antibody recognizing all ct-tubulins (Fig. 8 a' ), whereas only centrioles and primary cilia are stained by the antibody specific for acetylated ct-tubulin (Fig. 8 a) . After 3 min of recovery the cells have a normal cytoskeleton of microtubules (Fig. 8 b' ) that contains acetylated ct-tubulin only in short segments of microtubules, primarily but not exclusively in the centrosphere region (Fig.  8 b) . After 30 min of recovery the cells were indistinguishable from normal interphase cells, like those shown in Fig.  1, a and a' .
Similar patterns of staining were obtained with HeLa cells recovering from exposure to 0°C for 1 h. Cells were analyzed after 5, 10, and 15 min of culture at 37°C, as shown respectively in Fig. 9, a, b, and c, and a', b' , and c'. Microtubules containing acetylated a-tubulin are barely visible in the centrosphere region after 10 min of recovery (Fig. 9 b) , whereas the majority of cytoplasmic microtubules are already assembled (Fig. 9 b' ). After 15 min of recovery, short microtubules containing acetylated ct-tubulin are seen everywhere in the cells but primarily in the centrosphere region (Fig. 9 c) , whereas the antibody B-5-1-2 shows a normal cytoskeleton of microtubules (Fig. 9 c') . Acetylation of assembled tl-tubulin as detected by immunofluorescence microscopy lags behind the polymerization of nearly all microtubules.
The deacetylation of ¢t-tubulin was observed in 3T3 cells after 1 h of recovery from overnight exposure to 10 ~tM taxol. Fig. 10 , a and a' shows 3T3 cells after drug treatment and Fig.  10 , b and b' shows cells from the same culture after 1 h of recovery in normal medium. The bundles of microtubules that are formed in the presence of taxol, and the majority of acetylated ¢t-tubulin in polymerized form, disappears during recovery. Cells in Fig. 10 b' have microtubules that appear in normal configuration and that contain low or undetectable amounts of acetylated ¢t-tubulin (Fig. I0 b) .
The amounts of tubulin in 3T3 cells recovering from taxol was also measured by dot assay. The results are reported in Table I . After 1 h of recovery, the concentration of acetylated ct-tubulin returned to its pretreatment value (67 % decrease), while the concentration of ct-tubulin decreased by 20%. In an independent experiment, the amount of acetylated ¢t-tubulin was found to decrease by 51% after 30 min and by 68% after 1 h of recovery. The decrease in the amount of tubulin was 8 and 15 %, respectively. Therefore, during recovery, the deacetylation of the a-tubulin subunits occurs faster than the degradation of tubulin.
Assembly or disassembly and acetylation or deacetylation of microtubules, as observed by immunofluorescence microscopy, were not altered if the cells were treated with 10 lxg/ml cycloheximide during exposure and recovery in every condition described above.
Butyric acid, an inhibitor of histone deacetylases (1), was added to culture medium of 313 cells at the concentration of 5 mM during experiments of recovery from taxol exposure. The deacetylation of a-tubulin was not inhibited.
In Vitro Acetylated a-Tubulin of PtK2 Cells Binds the Antibody 6-11B-1
Double-label immunofluorescence of PtK2 cells showed that antibody 6-11B-l, which is specific for acetylated ct-tubulin, does not bind any microtubule structure. The antigenic determinant recognized by antibody 6-11B-1 is absent from the tt-tubulin either because the acetylation of the accepting lysine(s) does not occur or because the antibody 6-11B-1 does not recognize acetylated ct-tubulin from PtK2 cells. Alternatively, the antigenic determinants may be masked.
Chemical acetylation of all the proteins contained in crude extracts of PtK2 cells was performed using acetic anhydride, as described in Materials and Methods. Modified and unmodified products were analyzed by immunoblots of electrophoretograms and by a dot immunoassay. Although antibody 6-11B-1 did not bind to any protein in the unmodified extract, it did recognize one polypeptide in the acetylated extract. This polypeptide had the same electrophoretic mobility as the acetylated a-tubulin (not shown). Modified and unmodified PtK2 extracts contained approximately the same amount of a-tubulin, as shown by binding of the antibody B-5-1-2 to increasing amounts of cellular proteins (Fig. 11 b) . However, the antibody 6-lIB-1 bound only to modified extracts ( Fig. 11 a, solid circles) . The PtK2 ct-tubulins were treated with SDS and non-ionic detergents before being exposed to the antibody. Moreover, the unmodified a-tubulin did not react with the 6-lIB-1 antibody in the dot immunoassay or after SDS gel electrophoresis. Therefore, the possibility that an a-tubulin-associated protein masks the 6-11B-1 epitope seems very unlikely. Double-label immunofluorescence of PtK2 cells with antibodies 6-11B-1 and B-5-1-2 showed that acetylation of a-tubulin and formation of 6-11B-1 epitope can also be achieved by exposing methanol-fixed cells to acetic anhydride. This experiment is shown in Fig. 12, a and a' . After modification the microtubule structures of PtK2 cells stained by antibody 6-11B-1 or B-5-1-2 are indistinguishable. Control experiments of chemical acetylation of microtubules in situ were performed in 3T3 cells. After exposure to acetic anhydride the epitope recognized by the antibody 6-11B-1 was found in all microtubules of these cells (not shown).
The a-tubulins of PtK2 and 3T3 cells, which under normal conditions do not bind the antibody 6-11B-l, acquire one or more epitopes after chemical acetylation of the e-amino groups of all their lysines. Therefore, the lack of binding of the antibody 6-11B-1 to all microtubules of PtK2 cells and to the majority of microtubules of 3T3 cells is due to the lack of acetylation of the ~t-tubulin subunits in at least one site.
Discussion Experimental Approach
This study has two goals: to determine which set of microtubules contains an acetylated form of a-tubulin in mammalian cells in culture and to investigate whether a relationship exists between the acetylation of a-tubulin and the regulation of microtubule assembly. The experimental work has been based on the use of one monoclonal antibody, 6-111]-1, specific for acetylated a-tubulin. The specificity of the antibody was determined by experiments binding antibodies to ~t-tubulin from various sources that were described in a recent paper (12) . The antibody 6-11B-1 does not bind to acetylated lysine alone but recognizes an epitope present only in acetylated a-tubulin. Whether the antibody recognizes more than one epitope in the a-tubulin structure and whether it binds different forms of acetylated a-tubulin remains to be investigated.
We have used the antibody 6-11B-1 to perform immunofluorescence microscopy of methanol-fixed microtubules and binding assays to polypeptides electrotransferred or spotted on nitrocellulose sheets. The presentation of the antigenic determinant to the antibody may have been slightly different in each application, depending on the degree of denaturation of the a-tubulin. Therefore the binding activity of the antibody to the epitope could vary in each case. However, we have used the antibody in amounts spanning two orders of magnitude and against quantities of antigens varying ten times without noticing any change in the specificity of the binding activity. We have also acetylated in vitro a-tubulin together with many other polypeptides from 3T3 cells and found that after the acetylation the antibody 6-11B-1 only binds to acetylated a-tubulin. From these observations we concluded that the binding of the antibody 6-11B-1 to tubulin of mammalian cells indicates the presence of acetylated a-tubulin.
We have been able to detect by immunofluorescence microscopy specific microtubule frameworks and short segments of cytoplasmic microtubules binding the antibody 6-11B-1 in 3T3 and HeLa cells. Therefore the binding of the antibody 6-11B-1 reveals a discrete distribution of acetylated ct-tubulin in different microtubule structures and in single microtubules. The possibilities that unstained microtubules are not accessible to the antibody 6-11B-l, or that the antibody B-5-1-2 competes against the binding of the antibody 6-11B-l, were ruled out. In fact, binding assay to protein fractions from 3T3 and HeLa cells indicated that only a small percentage of ct-tubulin is acetylated. Moreover, all microtubules are stained by both antibodies if the ~t-tubulin is acetylated in vitro by acetic anhydride or in vivo in the presence of taxol. On the other hand, a lack of sensitivity of our detection system may have caused the incomplete recording of microtubule patterns containing acetylated ct-tubulin.
In addition to the immunofluorescence microscopy that revealed the distribution of acetylated tt-tubulin in the microtu- bules, immunoblots of electrophoretograms or dot binding assays were used to detect the total content of the modified subunit in protein preparations. Therefore, we could investigate by these last methods whether the increase of microtubules containing acetylated a-tubulin in the presence of taxol was due to the induction of acetylated a-tubulin or to new assembly of preexisting modified subunits. Moreover, we could exclude the hypothesis that large amounts of unpolymerized acetylated ¢t-tubulin are in equilibrium with microtubules containing the modified subunit. On the other hand, the absence or the presence of small amounts of modified subunits could not be evaluated because the detection procedure of antibody binding to dots or blots is sensitive to a minimum of 0.1 l~g of acetylated a-tubulin (12) . Protein sampies much higher than 100 ~tg could not be processed by our methods.
The Acetylation of a-Tubulin Occurs on Stable Microtubules
Acetylated a-tubulin was detected in microtubule frameworks such as axonemes, basal bodies (12, 8) , primary cilia, midbodies, and centrioles. Microtubules forming specific structures differ from single cytoplasmic microtubules in two properties. They have a specific position in the cell in relation to other microtubules or other cellular structures, and they are more stable under conditions of promoting disassembly of microtubules. Cytoplasmic single microtubules that contain acetylated ct-tubulin appear to make an exception to this model. However, the exception may be only apparent if order and stability exist in acetylated cytoplasmic microtubules and have not been recognized. This hypothesis is supported by the results of experiments performed on cells exposed to taxol. When order and stability among all cytoplasmic microtubules is created in the presence of taxol, the acetylation of ct-tubulin is extended to the whole microtubule population.
A proof of the existence of cytoplasmic microtubules that are more stable and contain acetylated a-tubulin was obtained by exposing different cells to antimitotic drugs that depolymerize microtubules. Drug-resistant acetylated microtubules were first observed in Chlamydomonas cell bodies (8) . The same kinds of microtubules were found in HeLa and 3T3 cells after exposure to colchicine or nocodazole in concentrations that do not cause side effects in tissue culture cells (2) . Therefore, the resistance of cytoplasmic microtubules containing acetylated a-tubulin to the depolymerizing action of nocodazole or colchicine appears to be intrinsic to their structure. Interestingly, a population of quasi-stable microtubules has been observed in interphase cells in culture that were microinjected with labeled tubulin in the absence of antimitotic drugs (14) . The presence of acetylated a-tubulin in these stable microtubules remains to be tested.
The resistance of microtubules to depolymerization may involve two steps. A first event causing the stabilization of microtubules could occur by end-or lateral-interaction between microtubules and other cellular entities. In a second step, the stabilization could be followed by acetylation of the ¢t-tubulin present in the microtubule structures. The stabilization and the acetylation of microtubules obtained in the presence of taxol suggest the occurrence of these separate events. However, in vitro the stabilization of microtubules with taxol does not involve the acetylation of a-tubulin (12) .
Acetylation and Deacetylation of Microtubules
The stability of cytoplasmic single microtubules must be transient since the cytoskeleton of microtubules is formed and destroyed in a continuous change of organization during the cell cycle (2) . Microtubules, instead of exchanging directly with a soluble pool of modified tubulin, may be acetylated after assembly and deacetylated before disassembly. The acetylation of a-tubulin appears to occur after microtubule assembly. Suggestive evidence of this phenomenon was obtained with 3T3 cells exposed to nocodazole or HeLa cells exposed to 0°C during recovery from exposure. The appearance of acetylated a-tubulin, as observed by immunofluorescence microscopy, lagged behind the polymerization of the majority of microtubules. A second point suggesting that the acetylation of ¢t-tubulin occurs postassembly derives from the analysis of Chlamydomonas flagella. There too, acetylated a-tubulin is present in axonemal microtubules and not in the pool of matrix proteins that does contain tubulin (5, 12) .
The enzymes involved in the acetylation and deacetylation of ct-tubulins appear to be constitutive in HeLa and 3T3 cells because acetylation and deacetylation of microtubules in these cell lines occur even when protein synthesis is in-hibited. The acetylase and deacetylase of a-tubulin are probably different from those modifying the histones, other proteins where the acetylation of the e-amino group of lysine is common (1) . In fact butyric acid, an inhibitor of histone deacetylases, does not affect the deacetylation of ¢t-tubulin in HeLa and 3T3 cells. An acetylase activity specific for ¢t-tubulin has been detected in Chlamydomonas flagella (3).
Finally, the epitope recognized by the antibody 6-11B-1 is absent in the histones of many cell types that were analyzed by immunoblotting of proteins.
The Acetylation of a-Tubulin Is a Common Event
All microtubules of 3T3 and HeLa cells contain acetylated ¢t-tubulin after exposure to taxol, and nearly every eukaryotic cell analyzed so far is provided with a subset of microtubules that binds the antibody 6-11B-1. The analysis has been extended to a variety of systems and tissues, varying from the unicellular organisms Chlamydomonas and Tetrahymena to cells of the nervous system, which are a common source of tubulin for polymerization experiments. In each case, wherever microtubules form a stable structure, as for instance the subpellicular microtubules of Trypanosoma brucei brucei, or lie in order, as in the neurites of primary culture of spinal cord from chick embryo, all the microtubules were found to contain acetylated ¢t-tubulin. In contrast, microtubules present in rapidly changing structures, as leading edges of 3T3 cells migrating into a wound formed by a needle in a monolayer of cells, do not bind the antibody 6-11B-1 (Piperno, G., and M. LeDizet, unpublished results). These observations indicate that the acetylation of tl-tubulin is very common and confirm the presence of acetylated tl-tubulin in stable and ordered arrays of microtubules.
In view of the common occurrence of acetylated ct-tubulin, it is surprising that the epitope recognized by the antibody 6-11B-1 is absent in PtK2 cells. That absence may be due to a lack of an acetylation system or to excessive activity of deacetylases. Both possibilities remain to be investigated.
PtK~, a second cell line from kidney of Potorous tridactylis, which was derived from a different animal, does not bind the antibody 6-11B-1 (Piperno, G., unpublished results). Therefore, the absence of the epitope apparently is not caused by an event of differentiation or mutagenesis.
On the basis of the observations described in this report, the acetylation of a-tubulin appears to occur in a variety of microtubule structures primarily after their assembly. Microtubules probably are stabilized by interaction with unknown cellular elements, and then are acetylated on the a-tubulin. These modified microtubules, to be kept in specific intracellular spaces, may require a lower amount of energy than those subjected to continuous assembly and disassembly.
